An Open Study to Evaluate the Efficacy, Safety and Sustained Effect of Clevudine Monotherapy or Adefovir and Clevudine Combination in Proportion to Roadmap Concept in Patients With Chronic Hepatitis B Associated Hepatocellular Carcinoma

NCT01263002 Phase 4 COMPLETED

An open study to evaluate the Efficacy, Safety of Clevudine monotherapy or Adefovir and Clevudine combination in Proportion to Roadmap Concept in patients with chronic hepatitis B Associated Hepatocellular Carcinoma

Details

Lead sponsor	Bukwang Pharmaceutical
Phase	Phase 4
Status	COMPLETED
Enrolment	33
Start date	2010-06
Completion	2013-09

Conditions

• Hepatitis B Associated Hepatocellular Carcinoma

Interventions

• clevudine, Adefovir

Primary outcomes

• Proportion of patients with HBV DNA levels < 60 IU/mL — 48 week

Countries

South Korea